BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 6638052)

  • 1. Hyperprolactinemia. Long-term effects of bromocriptine.
    Johnston DG; Prescott RW; Kendall-Taylor P; Hall K; Crombie AL; Hall R; McGregor A; Watson MJ; Cook DB
    Am J Med; 1983 Nov; 75(5):868-74. PubMed ID: 6638052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperprolactinemia in cases of infertility and amenorrhea.
    Furuhjelm M; Rydner T; Carlström K
    Acta Obstet Gynecol Scand; 1980; 59(2):137-41. PubMed ID: 6773290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine treatment of 42 hyperprolactinaemic women with secondary amenorrhoea.
    Bergh T; Nillius SJ; Wide L
    Acta Endocrinol (Copenh); 1978 Jul; 88(3):435-51. PubMed ID: 354299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of a prolactin-secreting pituitary tumor during long-term treatment with bromocriptine.
    Nillius SJ; Bergh T; Lundberg PO; Stahle J; Wide L
    Fertil Steril; 1978 Dec; 30(6):710-2. PubMed ID: 729834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid regression of a suprasellar extending prolactinoma after bromocriptine treatment during pregnancy.
    van Roon E; van der Vijver JC; Gerretsen G; Hekster RE; Wattendorff RA
    Fertil Steril; 1981 Aug; 36(2):173-7. PubMed ID: 6790306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial hypopituitarism and hyperprolactinemia: successful induction of ovulation with bromocriptine and human menopausal gonadotropins.
    Dawood MY; Jarrett JC; Choe JK
    Fertil Steril; 1982 Oct; 38(4):415-8. PubMed ID: 6811337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperprolactinemia and hypogonadism in the human female.
    Rolland R; Corbey RS
    Eur J Obstet Gynecol Reprod Biol; 1977; 7(5):337-48. PubMed ID: 400856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
    Pasinetti E; Schivardi MR; Falsetti L; Gastaldi A
    Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of bromocriptine in hyperprolactinemia and galactorrhea in Singapore.
    Tsakok FH; Yong YM; Ng CS
    Int J Gynaecol Obstet; 1985 Apr; 23(2):109-13. PubMed ID: 2862070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of tumor reduction in hyperprolactinemic women with extrasellar macroadenomas treated with bromocriptine.
    Boulanger CM; Mashchak CA; Chang RJ
    Fertil Steril; 1985 Oct; 44(4):532-5. PubMed ID: 4054327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of pregnancy on patients with hyperprolactinemia.
    Samaan NA; Leavens ME; Sacca R; Smith K; Schultz PN
    Am J Obstet Gynecol; 1984 Feb; 148(4):466-73. PubMed ID: 6696005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromocryptine therapy in cases of amenorrhea-galactorrhea.
    Mroueh AM; Siler-Khodr TM
    Am J Obstet Gynecol; 1977 Feb; 127(3):291-8. PubMed ID: 576372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bromocriptine for induction of ovulation in hyperprolactinemic amenorrhea.
    Nillius SJ
    Acta Eur Fertil; 1984; 15(2):83-91. PubMed ID: 6475464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and hormonal response to short-term intermittent versus continuous oral bromocriptine in hyperprolactinemic women.
    Parra A; Crespo G; Coria I; Espinosa de los Monteros A
    Int J Fertil Menopausal Stud; 1995; 40(2):96-101. PubMed ID: 7599666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the efficacy and safety of pergolide and bromocriptine in the treatment of hyperprolactinemia.
    Lamberts SW; Quik RF
    J Clin Endocrinol Metab; 1991 Mar; 72(3):635-41. PubMed ID: 1997518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic regulation of prolactin secretion in the hyperprolactinemic syndrome.
    Ayalon D; Eckstein N; Avidan S; Eshel A; L'Hermite M; Caufriez A; Spitz I; Zylber-Haran E
    Gynecol Obstet Invest; 1983; 16(2):97-106. PubMed ID: 6413305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of women with amenorrhea-galactorrhea treated with bromocriptine.
    Tartagni M; Nicastri PL; Diaferia A; Di Gesù I; Loizzi P
    Clin Exp Obstet Gynecol; 1995; 22(4):301-6. PubMed ID: 8777784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the prolactin serum isoforms secreted by a pituitary adenoma associated with therapy.
    Morán C; Tena G; Fonseca ME; Ochoa R; Bermúdez JA; Zárate A
    Arch Med Res; 1994; 25(1):1-3. PubMed ID: 8019107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of luteinizing hormone-releasing hormone testing in bromocriptine treatment of amenorrhea and hyperprolactinemia in patients with pituitary tumors.
    Lamberts SW; Docter R; De Jong FH; Birkenhäger JC; Kwa HG
    Fertil Steril; 1978 Mar; 29(3):287-90. PubMed ID: 346383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Return of menstruation and normalization of prolactin in hyperprolactinemic women with bromocriptine-induced pregnancy.
    Rasmussen C; Bergh T; Nillius SJ; Wide L
    Fertil Steril; 1985 Jul; 44(1):31-4. PubMed ID: 4007192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.